Lobbying Records (Page 1 of 3)
Bayer Limited
2025-09-21
Intent: Discussion and sharing of information relating to the geopolitical situation, specifically concerns surrounding the imposition of trade tariffs by the US. Understanding of the industry case for altering Ireland's position in the European Council relating to the GPL, as well as raising potential subjects for Ireland's EU Presidency agenda.
Details: IPHA Delegation to meet with An Tánaiste on EU health legislation and policy matters (including GPL and Ireland's EU Presidency), as well as the domestic issue of the negotiation of the pricing and supply agreement.
Officials: Simon Harris, Clare Mungovan, Hugh O’Connell, Stephen Kinsella, Joe Hackett, Colm Hayes, Maeve von Heynitz
Methods: Bayer were only involved in the meeting, with any associated activity and communication conducted by IPHA on the member companies' behalf. - Meeting
Teneo Strategy Ireland Limited
2025-09-19
Intent: To inform him of the proposal and provide information on biofuels
Details: On behalf of Fuels for Ireland, to provide information on the biofuels industry an on a time-bound Expert Group on Fiscal Policy and Fuels to define an overarching strategic framework — one that ensures taxation and non-tax measures are assessed together against principles of revenue stability, supp, ...
Officials: Stephen Kinsella
Methods: Meeting
Irish Pharmaceutical Healthcare Association
Current/Former DPOWhat is lobbying? (FAQ)2025-09-19
Intent: (a) Request to Irish Government to take account of the competitiveness of the pharmaceutical industry in Europe and not there dilute or reduce RDP. (b) Take account of the importance of the pharmaceutical industry in competitiveness of EU.
Details: (i) EU General Pharmaceutical Legislation and Irish Government position on Intellectual Property Rights. (ii) EU and Irish competitiveness and the pharmaceutical industry.
Officials: Simon Harris, Joe Hackett, Maeve von Heynitz, Stephen Kinsella, Colm Hayes, Hugh O’Connell
Methods: Meeting
Irish Pharmaceutical Healthcare Association
Current/Former DPOWhat is lobbying? (FAQ)2025-09-19
Intent: (i) The medicines reimbursement system should be designed and resourced to comply with the 2013 Health Act required for HSE decisions within 180 days excluding clock stops. (ii) Request for meeting to discuss IPHA proposals to address delays in the reimbursement system. (iii) Request to present IPHA Timeline data to the Oireachtas Health Committee.
Details: Future Framework Agreement - issues concerning timely reimbursement of medicines in Ireland.
Officials: Pádraig Rice, David Cullinane, Marie Sherlock, Simon Harris, Joe Hackett, Stephen Kinsella, Stephen Kinsella, Colm Hayes, ...
Methods: Email, Meeting, Virtual Meeting
Irish Pharmaceutical Healthcare Association
Current/Former DPOWhat is lobbying? (FAQ)2025-09-19
Intent: (i) The medicines reimbursement system should be designed and resourced to comply with the 2013 Health Act required for HSE decisions within 180 days excluding clock stops. (ii) Request for meeting to discuss IPHA proposals to address delays in the reimbursement system. (iii) Request to present IPHA Timeline data to the Oireachtas Health Committee.
Details: Future Framework Agreement - issues concerning timely reimbursement of medicines in Ireland.
Officials: Pádraig Rice, David Cullinane, Marie Sherlock, Simon Harris, Joe Hackett, Colm Hayes, Hugh O’Connell, Maeve von Heynitz, ...
Methods: Email, Meeting, Virtual Meeting
Irish Pharmaceutical Healthcare Association
Current/Former DPOWhat is lobbying? (FAQ)2025-09-19
Intent: (i) Ireland to advocate for no tariffs on medicines from US, and in the event of such, no reciprocal tariffs by the EU on medicines. (ii) Response to US s.232 process should position Ireland as a reliable supply chain partner, part of 'friends and allies of the US' to avoid tariffs on medicines.
Details: US Tariffs and EU - Irish Response
Officials: Simon Harris, Joe Hackett, Maeve von Heynitz, Stephen Kinsella, Colm Hayes, Hugh O’Connell, Clare Mungovan, Joe Neville
Methods: Meeting, Email
Irish Pharmaceutical Healthcare Association
Current/Former DPOWhat is lobbying? (FAQ)2025-09-19
Intent: (i) Ireland to advocate for no tariffs on medicines from US, and in the event of such, no reciprocal tariffs by the EU on medicines. (ii) Response to US s.232 process should position Ireland as a reliable supply chain partner, part of 'friends and allies of the US' to avoid tariffs on medicines.
Details: US Tariffs and EU - Irish Response
Officials: Simon Harris, Joe Hackett, Maeve von Heynitz, Stephen Kinsella, Colm Hayes, Hugh O’Connell, Clare Mungovan, Joe Neville
Methods: Meeting, Email
Pinnacle Public Affairs Ltd
Current/Former DPOWhat is lobbying? (FAQ)2025-09-19
Intent: To highlight the consequences of proposed EU-US Trade Tariffs on the Irish Whiskey Sector
Details: To engage with Key Stakeholders regarding proposed EU-US Trade Tariffs
Officials: Stephen Kinsella, Clare Mungovan, Joanne Lonergan, Martin Heydon, Brian Purcell, Deirdre Gillane, James O'Connor, Noel McCarthy, ...
Methods: Email, Phone call, Meeting
Pinnacle Public Affairs Ltd
Current/Former DPOWhat is lobbying? (FAQ)2025-09-19
Intent: To highlight the consequences of proposed EU-US Trade Tariffs on Med Tech Sector
Details: To engage with Key Stakeholders regarding proposed EU-US Trade Tariffs
Officials: Brian Keegan, Peter Burke, Stephen Kinsella, Joe Hackett, Joanne Lonergan, Micheál Martin, John Callinan, Deirdre Gillane
Methods: Email
Irish Exporters Association
2025-09-18
Intent: Share our industry expertise to inform Ireland's trade policy and exchange views with other stakeholders on country and regional specific developments.
Details: Government Consultative Group on Trade to engage with government of the latest and emerging trade developments and opportunties.
Officials: Simon Harris, James Lawless, Niamh Smyth, Martin Heydon, Joe Hackett, Brendan Gleeson, Declan Hughes, Ronnie Downes, ...
Methods: The IEA has attended and contributed to three meetings of the Government Trade Forum. These regular meetings involve government and industry stakeholders as well as many of the DPO's outlined below. - Meeting